Angiotensin converting enzyme 2 (ACE2): Virus accomplice or host defender
Jiyan WangiD, Hongkai Chang, Yaya Qiao, Huanran SuniD, Xichuan LiiD, Shuofeng YuaniD, Shuai ZhangiD, Changliang Shan
Abstract
The current coronavirus disease-19 (COVID-19) caused by the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has seriously disrupted the daily life of human, mainly attributed to the fact that we know too little about SARS-CoV-2. Increasing studies show that viral infection alters host cells glucose metabolism, which is crucial for viral nucleic acid replication. Here, we integrated RNA-sequencing results and found that SARS-CoV-2 infection alters the aerobic glycolysis, pentose phosphate pathway (oxiPPP), and DNA replication in lung tissues and cells. However, the direction of metabolic flux and DNA replication were dominated by angiotensin-converting enzyme 2 (ACE2), a host cell-expressed viral receptor protein. More interesting, although hosts with high expression of ACE2 are more likely to be infected with SARS-CoV-2, the invading virus cannot perform nucleic acid replication well due to the restriction of glucose metabolism, and eventually resulting prolonged infection-cycle or infection failure. Our findings, after a typical epidemiological investigation and modeling analysis, preliminarily explain the reasons for the emergence of asymptomatic infections or lower copy virus at early stage in host with higher ACE2 levels, which will provide important help for the development of more accurate and effective detection methods for diagnosing COVID-19. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=103 SRC="FIGDIR/small/483197v1_ufig1.gif" ALT="Figure 1"> View larger version (70K): org.highwire.dtl.DTLVardef@b51fcforg.highwire.dtl.DTLVardef@13b7f9corg.highwire.dtl.DTLVardef@136fe46org.highwire.dtl.DTLVardef@16fc92a_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.21
- Field percentile
- top 48%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increasing Host Cellular Receptor--Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV Infection
P.-H. Wang·bioRxiv·Feb 24, 2020
- A novel isoform of ACE2 is expressed in human nasal and bronchial respiratory epithelia and is upregulated in response to RNA respiratory virus infection
Cornelia Blume, Claire L. Jackson, … Vito Mennella·Nature GeneticsPeer-reviewed·Jan 11, 2021
- Oral epithelial expression of angiotensin converting enzyme-2: Implications for COVID-19 diagnosis and prognosis.
M. Srinivasan, S. L. Zunt, L. I. Goldblatt·bioRxiv·Jun 22, 2020
- Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV
Y. Qiu, Q. Wang, … X.-Y. Ge·Transboundary and Emerging DiseasesPeer-reviewed·Sep 5, 2020
- SARS-CoV-2 infection suppresses ACE2 function and antiviral immune response in the upper respiratory tract of infected patients
L. Gutierrez-Chamorro, E. Riveira-Munoz, … E. Ballana·bioRxiv·Nov 18, 2020
- Recombinant ACE2 Expression is Required for SARS-CoV-2 to Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
J. Nascimento Conde, W. R. Schutt, … E. R. Mackow·bioRxiv·Nov 10, 2020